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Abstracts / Urological Science 26 (2015) S50eS81 S69reason and Digital examination should be performed. This case was added
to the database and hopefully to raise the awareness of this disorder.Other
NDP074:
EXTRAPERITONEAL CYSTIC LYMPHANGIOMA WITH PRESENTATION OF
LOWER URINARY TRACT SYMPTOMS
Hsuan-Ying Ho, Kun-Hung Shen. Division of Urology, Department of
Surgery, Chi Mei Medical Center, Tainan, Taiwan
Case report: Extraperitoneal lymphangiomas are rare and usually
asymptomatic. The incidence retroperitoneal lymphangiomas is approxi-
mately 1%. The symptoms often depend on the location of the tumor and
the tumor size. We'd like to share a case in Chi-Mei hospital. A 47-year-old
man suffered from urinary frequency and nocturia for 2 years. The
symptoms worsened recently. Physical examination found low abdominal
dullness and palpable mass without tenderness. Sonography found post-
voiding residual urine 914ml. Abdominal CT showed a huge cystic lesion in
lower abdomen with compression to urinary bladder and bilateral ureter.
The patient then received surgical excision of the tumor. During the sur-
gery, a huge cystic lesion containing 3100cc ﬂuid with adhesion to urinary
bladder, left external iliac vessels, and obturator nerve was found, and was
removed smoothly. The post-operative pathology reported in cystic lym-
phangioma. The patient's post-operative condition remained ﬁne, and no
complication was noted.Oncology
NDP075:
LONG TERM HEALTH EFFECT OF ILEAL CONDUIT URINARY DIVERSION
Hao Lun Luo, Po Hui Chiang. Divisions of Urology, Department of Surgery,
Kaohsiung Chang Gung Medical Center, Kaohsiung, Taiwan
Purpose: Ileal conduit urinary diversion (ICUD) is the most common
procedure after radical cystectomy. Distributions of potential complica-
tions have been reported, but there is not adequate number of patients
with ICUD and bladder preservation control (transurethral resection of
bladder tumor, TURBT) for long-term follow-up duration. The aim of this
study is to compare the long-term health effect in patients who had un-
dergone ICUD during long term observation.
Materials and Methods: Data for this population-based cohort study
were obtained from the Taiwan National Health Insurance Research
Database (NHIRD). This study included 43,123 patients with diagnosis of
bladder cancer between 1997 and 2006. Only cancer-free patients
without chemotherapy and other types of urinary diversions and who
lived for longer than ﬁve years were included for analysis. All enrolled
subjects were followed-up until the end of 2011. The patients with
bladder cancer underwent ICUD after radical cystectomy or TURBT only
in this series.
Results: Compared to the patients who had undergone bladder preser-
vation procedure only, patients who had undergone ICUD after cystectomy
were noted to be independently associated with postoperative de novo
UTI, UTI with septicemia, and CKD (all the p < 0.001, HR ¼ 1.49, 5.02 and
3.07 respectively). The limitations of this study are its retrospective and
multicenter designs.
Conclusion: This study presents a nationwide cohort that ICUD after
radical cystectomy may cause higher incidence of UTI, UTI with septicemia
and CKD compared with TURBT only during long-term follow up.
NDP076:
LEAVING RESIDUAL URETERAL ORIFICE AFTER HAND-ASSISTED
RETROPERITONEOSCOPIC NEPHROURETERECTOMY FOR UPPER TRACT
UROTHELIAL CANCER IS LESS TIME CONSUMING AND DO NOT AFFECT
OVERALL SURVIVAL
Yu-Dan Chen, Wen-Horng Yang, Chien-Hui Ou. Department Of Urology,
National Cheng-Kung University Hospital, Medical College, National Cheng-
Kung University, Tainan, TaiwanPurpose: To determine the impact of residual ureteral oriﬁce after hand-
assisted retroperitoneoscopic nephroureterectomy (HARN) for primary
upper tract urothelial cancer (UTUC).
Materials and Methods:We retrospectively reviewed patients with upper
UTUC that had undergone HARN. Of these 75 patients, 37 of which
belonged to the study group with ipsilateral residual ureteral oriﬁce (RUO)
due to difﬁcult operative approach (because of obesity, previous pelvic
operation or radiation therapy, etc), while 38 patients served as controls
with no residual ureteral oriﬁce (NUO) postoperatively by follow up
cystoscopy. We analyzed intravesical recurrence, local recurrence, and
survival to assess the signiﬁcance between two groups.
Results: Baseline demographics were comparable in both groups. In
comparison with the RUO group, the NUO group was associated with a
longer total operative time (150± 78 vs.200± 115 mins, p ¼ 0.03). Bladder
recurrence was observed in 22 out of 37 (59.5%) in the RUO group and in 10
out of 38 (26%) in the NUO group (p ¼ 0.001) during median 39.7 months
follow up. There was a signiﬁcant difference in bladder cancer recurrence-
free rate in the NUO group versus RUO group (p ¼ 0.04). Forty-eight
percent (24/50) of ﬁrst intravesical recurrence had a tendency of recur-
rence occurring near the area of ipsilateral ureteral oriﬁce/scar especially
in RUO group (57.5% vs.40 %, p ¼ 0.04). Most patients (94%) in whom a
bladder tumor developed postoperatively were superﬁcial and underwent
transurethral resection of the bladder tumor. The survival rate was not
signiﬁcantly different when we compared the RUO and NUO groups
(p ¼ 0.42).
Conclusion: Leaving residual ureteral oriﬁce is less time consuming,
although increase the risk of intravesical recurrence, did not undermine
survival after HARN for primary UTUC.
NDP077:
COMPARISON OF CLINICAL PRACTICE GUIDELINES IN PROSTATE
CANCER BETWEEN JAPAN AND TAIWAN
Chih-Cheng Lu, Wen-Chou Fan, Tse-Chou Cheng. Division of Urology,
Department of Surgery, Chi Mei Medical Center, Liouying, Tainan
Purpose: This study is to compare the clinical practice guidelines in
managing prostate cancer (CaP) between Japan and Taiwan.
Materials and Methods: CPGs by Japanese Urological Association (JUA)
and Taiwan Cooperation Oncology Group (TCOG) were reviewed.
Results: Up to March 2015, the online guideline for CaP by JUA was
available since 2006 (updated in 2008).The latest CPG for CaP by TCOGwas
available in 2010 (the third edition since 1999). Neither JUA nor TCOG had
English version so far. JUA had a revised printed version published in April
2012. Evidence based medicine (EBM) was clearly applied by JUA but not
by TCOG. In diagnosis, MRI is not suggested before transrectal prostatic
biopsy in TCOG. The reference range of serum prostate speciﬁc antigen
(PSA) was based on Japanese people data with age speciﬁc consideration
by JUA, but was based on data from USA not from Taiwanese data by TCOG.
The age to start PSA checking was 55 years mentioned by JUA and 50 years
by TCOG. In treatment, watchful waiting therapy was more detailed by JUA
than by TCOG. Proton and heavy ion therapy were discussed in JUA but not
in TCOG. Chemoprevention of CaP was mentioned in JUA but not in TCOG.
Phytotherapy were not approved by JUA nor TCOG. For localized CaP, pri-
mary hormone therapy was recommended in JUA but not mentioned in
TCOG.
Conclusion: EBM is essential for modern CPGs. Variation exists between
Japanese and Taiwanese editions. From views of EBM, revision of Taiwa-
nese CPG for CaP is strongly suggested. Further study is needed to conﬁrm
these ﬁndings.
NDP078:
BLADDER CANCER FOLLOWING NEPHROURETERECTOMY WITH
BLADDER CUFF EXCISION FOR UPPER URINART TRACT MALIGNANCY:
COMPARING THE INCIDENCE BETWEEN SQUAMOUS CELL CARCINOMA
AND UROTHELIAL CARCINOMA
Li-Hua Huang 1, Chuan-Shu Chen 2, Yen-Chuan Ou 2. 1Divisions of Urology,
Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taiwan;
2Divisions of Urology, Department of Surgery, Taichung Veterans General
Hospital, Taichung, Taiwan
Abstracts / Urological Science 26 (2015) S50eS81S70Purpose: In upper urinary tract (UUT), squamous cell carcinoma (SCC) and
urothelial carcinoma (UC) are two different disease in its etiology, inci-
dence and prognosis. Due to paucity of the study in SCC, we treat it just as
UC. However, we believe the therapeutic and following protocols for the
two diseases are different. In this study, we compare the bladder recur-
rence rate in these two malignancies.
Materials and Methods: From January 2000 to December 2007, 327 pa-
tients were diagnosed as upper urinary tract malignancy. Their clinical and
pathological characteristics were retrospectively reviewed. There were
294 pure UC (90.0%), 24 UCwith squamous differentiation (SqD) (7.3%) and
9 pure SCC (2.7%) patient. These patients all received RNU initially. Kaplan-
Meier method was used to estimate bladder recurrence free survival (RFS).
The recurrence curve is compared by log rank test. The statistical signiﬁ-
cance was set as p&0.05.
Results: The 5-year RFSs of bladder were 67.9%, 70.4 and 100% in UC, UC
with SqD and SCC groups respectively. Pairwise comparisonwas done., and
here was no signiﬁcant difference in bladder RFS between two groups. The
p-value of log-rank test comparing UC and SCC is 0.061. Although not
statistically signiﬁcant, there was a trend that patients with UUT-SCC had
less bladder recurrence after initially operative management.
Conclusion: There was a statistical trend that patients with UUT-SCC had
less bladder recurrence after initially operative management. It did not
reach signiﬁcance because of the small number of patients with SCC.
NDP079:
ANDROGEN-DEPENDENT PROSTATE CANCER CELLS INTO NON-
ANDROGEN DEPENDENT PROCESS THE ROLE OF MICRORNA
Jui-Ming Liu 1, Ren-Jun Hsu 2. 1Division of Urology, Department of Surgery,
Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan,
Taiwan; 2Department of Pathology and Graduate Institute of Pathology and
Parasitology Tri-Service General Hospital, National Defense Medical Center,
Taipei, Taiwan
Purpose: To compare the observed androgen-dependent prostate cancer
cells (LNCaP), transformed into a differential expression of androgen-in-
dependent prostate cancer cells (LNCaP -androgen independent) process
microRNA explore highmicroRNA expression differences in the conversion
process regulatory mechanisms may play its target genes.
Materials andMethods: LNCaP, anti-androgen drugs (high expression and
low expression for 3 months LNCaP and LNCaP -androgen independent
transformed into microRNA expression between cells, choose large dif-
ferences in the use of Agilent to validate, and bioinformatics analysis,
looking for differences in the expression of microRNA target gene. Lucif-
erase reporter assay to demonstrate the use of the target gene does. This
will take advantage of siRNA way to suppress or to increase the perfor-
mance of high performance differences of microRNA, microRNA to conﬁrm
the high performance difference does affect the formation of androgen-
independent prostate cancer cells
Results: Under the gene chip can get more than 100 have differences in
microRNA, but we only pick the difference more than 10 times higher
than the microRNA analysis to identify prostate cancer cells are most
likely to affect the transition from androgen-dependent a non-androgen
dependent microRNA. We found miR-221 is the highest performance
microRNA.
Conclusion: The miR-221 is one of the highest performance difference
does affect the formation of androgen-independent prostate cancer cells.
NDP080:
ADULT WILMS' TUMOR: SINGLE INSTITUTION EXPERIENCE AND
REVIEW OF LITERATURES
Yu-Hua Shau 1,2, Sheng-Tang Wu 1, Shou-Hung Tang 1, Tai-Lung Cha 1, Chih-
Wei Tsao 1, En Meng 1, Dah-Shyong Yu 1, Guang-Huan Sun 1, Chien-Chang
Kao 1. 1Division of Urology, Department of Surgery, Tri-Service General
Hospital, National Defense Medical Center, Taipei, Taiwan; 2Division of
Urology, Department of surgery, Taoyuan armed forces general hospital,
Taiwan
Purpose: Wilms' tumor (nephroblastoma) is the most common solid pri-
mary renal malignancy in children but extremely rare in adult population.We present single institution experience of adult Wilms' tumor in order to
assess the clinical characteristics, radiological features, and surgical
prognosis.
Materials and Methods: A retrospective review was carried out to
investigate the patients with adultWilms' tumor at the Tri-Service General
Hospital during a 45-year period (1970 - 2014). Seven patientsS 16 years
old (one female and six male; median age at the time of diagnosis of 24
years; range 24 - 48 years) were staged according to the National Wilms'
Tumor Study (NWTS) staging system as follows: 3 patients had stage II
disease, 2 patients had stage III disease and 2 patients had stage IV disease
Results: The most common presentation is ﬂank pain (57%) followed by
palpable mass (43 %). Only one patient presented with gross hematuria.
Four patients underwent renal arteriography which all disclosed irregular,
tortuous vessel pattern with faint tumor stain. All patients underwent
radical nephrectomy (one hand-assisted laparoscopic nephrectomy and 6
open transperitoneal nephrectomy). Two patients developed lung metas-
tases after radical surgery. All but one patient received multimodal ther-
apy, including surgery, chemotherapy and radiation therapy. The mean
disease-free survival is 81months. Three-year and ﬁve-year survival rate is
60 % and 50 % separately.
Conclusion: Selective renal arteriography provides valuable diagnostic
hint in adult Wilms' tumor. Using multimodality therapy, improved
prognosis could be achieved.
NDP081:
EFFICACY OF SWITCHING THERAPY OF LUTEINIZING HORMONE-
RELEASING HORMONE ANALOGUE FOR ADVANCED PROSTATE CANCER
Yuan-Chi Shen, Chih- Hsiung Kang, Po-Hui Chiang. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital, Taiwan
Purpose: To determine the efﬁcacy of switching therapy with a second
LHRH analogue after PSA progression for advanced prostate cancer.
Materials and Methods: Between December 2005 to September 2013,
there were 200 patients with nodal positive, metastatic prostate cancer
or disease progression after deﬁnite treatment receiving continuous
LHRH analogues therapy with monthly Depot leuprorelin (sc)
acetate 3.75mg/vial (LA) or Gorserelin acetate (sc) 3.6mg /vial (GA). If
the patients had castration resistant prostate cancer, the treatment
choice of switching therapy (LA to GA or GA to LA) before entering
chemotherapy was given.The LH, testosterone level and PSA change
were recorded.
Results: 127 patients receiving LA as initial ADT therapy and the other
73 patients were in GA therapy. A total of 92 patients (54 patients got
LA to GA and 38 got GA to LA) got LHRH analogue switching therapy.
The effect of LH and testosterone reducing before and after switching
therapy was comparable between two groups and the increasing PSA
level after three-months treatment was seen in both groups (median
PSA: 15.7 to 67.7ng/ml in LA to GA group and 15.2 to 71.4ng/ml in GA to
LA group).
Conclusion: Switching therapy for patients with PSA progression after
ADT has no efﬁcacy of further PSA decrease.
NDP082:
FUNCTIONAL OUTCOME PREDICTION AFTER PARTIAL NEPHRECTOMY
USING R.E.N.A.L NEPHROMETRY, PADUA CLASSIFICATION AND
CENTRALITY INDEX SCORE
Ding-Po Lin, Huang-Kuang Chang, Stone Yang, Jong-Ming Hsu, Yung-
Chiong Chow, Wei-Kung Tsai, Pai-Kai Chiang, Marcelo Chen, Chih-Chiao
Lee, Wun-Rong Lin. Department of Urology, Mackay Memorial Hospital,
Taipei, Taiwan
Purpose: Several scoring system have been proposed to quantify surgical
complexity, and provide insight into expected perioperative and post-
operative surgical outcomes following partial nephrectomy. However, it is
still unclear that which of the scoring system has better outcome in pre-
dicting functional outcome after partial nephrectomy. In the present
study, we assess the use of R.E.N.A.L., PADUA and centrality index scores
to predict the renal function for patients who underwent partial
nephrectomy.
